Vimeo
LinkedIn
Instagram

Author Bios

Articles by this author:

  • The unique shape of the Covid-19 crisis and accompanying recession has meant some industries have thrived while others have dived. In caricature, everyone now uses Zoom and Peloton, while offices and gyms were forced to close.

  • Could a vaccine change market leadership? When will enough doses of FDA-approved Covid-19 vaccine(s) to inoculate 25 million people be distributed in the US? The superforecasters of the Good Judgement Project believe there is a 93% probability we will have an FDA-approved vaccine in a year, and enough of it to inoculate 25 million people in the US. This is up from just 20% in the dark days of April.

  • Buy good companies. And own them forever. As investment approaches go, it is seductively simple. In a financial world that often looks confused, and in places absurd, buying and holding a portfolio of high-quality companies has evident appeal. Ten years into a bull market, the approach is back in vogue. Owning high-quality equities has worked well over the past 20 years.

    However, from today’s starting point – with high valuations, and a cosy consensus around the business fundamentals – these high-quality stocks look unappealing. Are these supposedly ‘safe’ stocks now, counterintuitively, one of the least attractive parts of the market? Duncan MacInnes

  • Duncan MacInnes, investment director, discusses Covid-19: how it has changed the investment landscape, the impact on the Ruffer portfolio and what could happen next.

  • Ronald Reagan ran in 1984 with a famous TV commercial which started with the line ‘It’s morning in America’. This was to signify that the best was yet to come. We think there is a chance, just a chance, that the UK could also be at the start of an exciting period.

Click here >>
Close